Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Tofacitinib may help regrow hair in alopecia areata patients.

Topical tacalcitol can treat psoriasis by acting directly on skin cells.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Tacrolimus treatment for autoimmune hepatitis can cause hair loss.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

OCT can effectively examine and reveal details about human hair and scalp conditions.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Onabotulinum toxin A may help treat trichotillomania and promote hair growth.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Hair or fiber wrapped tightly around a toe can lead to serious injury if not treated quickly.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Telocytes have potential in therapy and tissue regeneration, but challenges in identification and cultivation remain.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Tofacitinib can help regrow hair in about 50% of people with moderate-severe alopecia areata.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.